Avantax Planning Partners’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-750
Closed -$2.71K 397
2023
Q1
$2.71K Buy
+750
New +$2.71K ﹤0.01% 374